Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

Clinical trial NCT00871000 · COMPLETED

Trial details

NCT number: NCT00871000
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria Poliomyelitis

Start date: 2009-04-01
Primary completion: 2009-11-18
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.